Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Creative Medical Technology Holdings (CELZ) Amortization - Intangibles (2016 - 2025)

Creative Medical Technology Holdings has reported Amortization - Intangibles over the past 10 years, most recently at $30949.0 for Q4 2025.

  • Quarterly Amortization - Intangibles rose 36.71% to $30949.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $123327.0 through Dec 2025, up 11.66% year-over-year, with the annual reading at $123327.0 for FY2025, 11.66% up from the prior year.
  • Amortization - Intangibles was $30949.0 for Q4 2025 at Creative Medical Technology Holdings, roughly flat from $31059.0 in the prior quarter.
  • Over five years, Amortization - Intangibles peaked at $31059.0 in Q3 2025 and troughed at $22639.0 in Q4 2024.
  • The 5-year median for Amortization - Intangibles is $23021.0 (2021), against an average of $25626.6.
  • Biggest five-year swings in Amortization - Intangibles: soared 39.71% in 2021 and later fell 11.29% in 2024.
  • Tracing CELZ's Amortization - Intangibles over 5 years: stood at $23021.0 in 2021, then changed by 0.0% to $23021.0 in 2022, then grew by 10.86% to $25521.0 in 2023, then fell by 11.29% to $22639.0 in 2024, then skyrocketed by 36.71% to $30949.0 in 2025.
  • According to Business Quant data, Amortization - Intangibles over the past three periods came in at $30949.0, $31059.0, and $30742.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.